Jiangsu Hengrui Medicine Co., Ltd.

This study tested whether a new injectable medication called HR17031 works better and is safer than a standard long-acting insulin (glargine) for adults with type 2 diabetes. It involved 393 people whose blood sugar was not well controlled on their current insulin and pill regime…

This study tested a new muscle relaxant drug called HRS-9190 for use during surgery. It was compared to the standard drug rocuronium in 70 adults having elective surgery. Researchers measured how well it worked for placing breathing tubes and how quickly patients recovered muscle…

This study tested the safety and early effectiveness of an experimental drug called SHR-A1811 in people with advanced solid tumors that have a specific marker called HER2. The trial involved 396 participants whose cancer had progressed despite standard treatments. Researchers mon…

This was the first study in people to test a new oral drug called HRS7415 for advanced cancers. It involved 38 patients and aimed to find a safe dose and understand how the body processes the drug. The main goals were to check for side effects and see if the drug showed any early…

This study tested if a new oral tablet (SHR7280) works as well as a standard injection (ganirelix) for women undergoing IVF. The goal was to prevent early ovulation during the egg-stimulation phase of treatment. About 317 married women with infertility participated to see if the …

This study tested a new injectable drug called HR17031 against a standard insulin (glargine) in Chinese adults whose type 2 diabetes was not well controlled with oral medications. The main goal was to see if HR17031 could lower long-term blood sugar levels (HbA1c) as effectively …

This study tested whether a daily pill called pyrotinib works better than standard chemotherapy (docetaxel) for people with advanced non-squamous lung cancer that has a specific HER2 gene mutation and has worsened after initial platinum-based chemotherapy. It involved 151 partici…

This study tested the safety and effectiveness of a new immunotherapy drug called SHR-1210 when given with other cancer drugs. It involved 157 people with advanced liver cancer or bile duct cancer who had either tried previous treatments or were newly diagnosed. The main goal was…

This study tested whether combining two drugs, SHR-1210 (an immunotherapy) and apatinib (a targeted therapy), could help control advanced liver cancer. It involved 190 patients whose cancer had worsened or who could not tolerate the standard treatment. The goal was to see if this…

This study tested a combination of two drugs, SHR-1210 and apatinib, for people with advanced non-small cell lung cancer whose cancer had grown after standard chemotherapy. The main goals were to see how safe the combination was and how well it worked to shrink tumors. It involve…

This study tested whether a new capsule called HR19042 could safely reduce protein loss in the urine for people with IgA nephropathy, a kidney disease. It compared the capsule to a placebo (dummy pill) in 316 adults with confirmed disease. The main goal was to see which dose work…

This large study tested whether adding two newer drugs (camrelizumab and apatinib) to standard chemotherapy works better than chemotherapy alone for advanced stomach cancer. The trial involved 885 patients who hadn't received previous treatment for their advanced cancer. Research…

This study tested whether a new medication called HR091506 works as well as an existing drug (febuxostat) to lower uric acid and control gout in adults. It involved 765 people with gout and high uric acid levels over 28 weeks. The main goal was to see if the new pill could safely…

This early-stage study tested a new drug called SHR-A1811 in 101 patients with advanced stomach or colorectal cancer that had stopped responding to standard treatments. The main goals were to find a safe dose and check for early signs that the drug might help control these cancer…

This study tested whether adding a second drug (rivoceranib) to an immunotherapy drug (camrelizumab) works better than the immunotherapy alone at preventing liver cancer from returning after surgery or ablation. The trial involved 251 patients who had their liver cancer removed b…

This study tested a new sedative medicine for adults in intensive care who need help breathing from a machine. The goal was to see if the drug could keep patients comfortably sedated for at least three days and allow them to wake up quickly when needed. Researchers measured how w…

This was an early safety study of a new drug called HRS-9190, designed to relax muscles during surgery. It tested the drug in 49 healthy adults to see if it was safe, how the body handled it, and how well it worked. The study also looked at how another drug could reverse its effe…

This study tested a new sedative medicine for adults in intensive care who are on breathing machines. The goal was to see if the drug could safely keep patients comfortably calm and at the right level of sedation for most of their treatment time. Researchers compared it to an exi…

This study examined how the antibiotic rifampicin affects how the body processes an experimental prostate cancer drug called HRS-5041. Researchers gave both drugs to 16 healthy male volunteers to measure drug levels in the blood. The goal was to understand potential drug interact…

This study looked at how a new injection for severe pain after surgery, called SHR8554, moves through and leaves the bodies of people with reduced kidney function. It compared 20 participants, some with kidney problems and some healthy, to see if the drug behaves differently. The…

This study aimed to observe the safety of the sedative drug remazolam in real-world medical practice. It followed 2000 patients in China who received the drug for sedation during painless stomach and colon examinations. The main goal was to collect information on any side effects…

This early-stage study aimed to understand how a new drug called SHR7280 might interact with five other common medications. It involved 20 healthy male volunteers to see if taking SHR7280 changes how the body processes these other drugs. The main goal was to gather safety data, n…

This study observed over 1,200 patients in China who received the sedative drug remimazolam during surgery or a lung exam called a bronchoscopy. The goal was to collect real-world information on the drug's safety and any side effects. It was an observational study, meaning patien…

This early-stage study tested a new muscle relaxant called HRS-9190 in healthy adults to see if it's safe and how the body processes it. Researchers gave increasing doses to 53 healthy volunteers aged 18-45 and monitored for side effects. The main goal was to understand how much …

This study aimed to see if a new, experimental long-acting pain injection works the same way in the body as an already approved version. It involved 36 healthy volunteers who received both injections. Researchers measured drug levels in the blood to compare them and checked for s…